Pune Biomanufacturing Study Strengthens Pandemic Preparedness
Pune: Scientists from the Indian Institute of Science Education and Research (IISER) Pune have contributed to an international study demonstrating that decentralised laboratory production of essential biological materials could improve preparedness for future health emergencies. The findings suggest that distributed manufacturing models may strengthen healthcare resilience by reducing reliance on global supply chains that often face disruption during pandemics.
Published in the peer-reviewed journal Science Advances, the research involved laboratories across India, Canada, Brazil, Chile and Colombia working together to evaluate whether biological reagents could be manufactured consistently using shared scientific protocols and locally available laboratory infrastructure. The study highlights how decentralised biomanufacturing could become a strategic component of emergency public health planning. The initiative emerged from lessons learned during the COVID-19 pandemic, when many countries experienced shortages of diagnostic materials and laboratory supplies due to international transport disruptions and concentrated manufacturing networks. Researchers believe creating regional production capabilities can help governments respond more rapidly when conventional supply chains become constrained. At IISER Pune, researchers participated in validating laboratory methods that enabled reliable production of proteins using synthetic DNA and cell-free biological systems. The team assessed whether laboratories equipped with standard research facilities could reproduce high-quality biological materials while maintaining consistency across different geographical locations.
The multinational collaboration also demonstrated that laboratory-prepared cell-free extracts could be transported between participating institutions and successfully reproduced without compromising protein production. According to scientific experts, this finding is significant because reproducibility is essential before distributed manufacturing approaches can support diagnostics, research and emergency response programmes. Researchers further explored paper-based molecular diagnostic technologies capable of detecting viral genetic material using synthetic biology techniques. The study also examined laboratory-scale production of vaccine-related proteins through freeze-dried biological systems, demonstrating proof of concept for rapid local manufacturing during infectious disease outbreaks. While these approaches remain complementary to established industrial production, they could provide an additional layer of resilience when demand outpaces conventional manufacturing capacity. Urban health specialists increasingly recognise that resilient cities depend not only on hospitals and healthcare infrastructure but also on secure scientific supply networks. Distributed laboratory manufacturing could reduce delays in obtaining critical reagents, enabling research institutions, diagnostic laboratories and public health agencies to respond more effectively during disease outbreaks. Such capabilities are particularly relevant for rapidly growing metropolitan regions where population density can accelerate disease transmission.
The study also underscores the value of international scientific collaboration in strengthening local innovation ecosystems. Researchers from participating institutions developed and tested common methodologies despite operating in different countries, demonstrating how shared scientific standards can improve preparedness without requiring highly centralised production facilities. As cities continue investing in health resilience alongside climate and infrastructure planning, decentralised biomanufacturing may offer policymakers an additional mechanism to safeguard essential diagnostic and research capabilities. Experts suggest that strengthening regional scientific infrastructure, skilled research capacity and collaborative networks could help ensure faster, more equitable access to critical biological materials during future public health emergencies.